| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines.
|
J Neurosci
|
2005
|
1.75
|
|
2
|
The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines.
|
J Psychopharmacol
|
2005
|
1.32
|
|
3
|
STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating.
|
Behav Brain Res
|
2005
|
1.23
|
|
4
|
Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
|
J Psychopharmacol
|
2006
|
0.94
|
|
5
|
Genetic mapping of variation in spatial learning in the mouse.
|
J Neurosci
|
2003
|
0.92
|
|
6
|
The role of GABAbeta2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole.
|
Eur J Neurosci
|
2006
|
0.90
|
|
7
|
A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
|
J Med Chem
|
2006
|
0.89
|
|
8
|
The in vivo properties of pagoclone in rat are most likely mediated by 5'-hydroxy pagoclone.
|
Neuropharmacology
|
2006
|
0.88
|
|
9
|
Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviour.
|
Neuropharmacology
|
2004
|
0.88
|
|
10
|
Gamma-aminobutyric acid type A receptor beta 2 subunit mediates the hypothermic effect of etomidate in mice.
|
Anesthesiology
|
2004
|
0.86
|
|
11
|
Contribution of GABA(A) receptors containing α3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys.
|
Psychopharmacology (Berl)
|
2010
|
0.83
|
|
12
|
Reinforcing effects of compounds lacking intrinsic efficacy at α1 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys.
|
Neuropsychopharmacology
|
2012
|
0.81
|
|
13
|
Novel aspects of accumulation dynamics and A beta composition in transgenic models of AD.
|
Neurobiol Aging
|
2004
|
0.81
|
|
14
|
Designing drugs for the treatment of female sexual dysfunction.
|
Drug Discov Today
|
2007
|
0.79
|
|
15
|
Effects of reinforcement schedule on facilitation of operant extinction by chlordiazepoxide.
|
J Exp Anal Behav
|
2005
|
0.79
|
|
16
|
Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxiety.
|
J Med Chem
|
2006
|
0.79
|
|
17
|
Effects of drugs that potentiate GABA on extinction of positively-reinforced operant behaviour.
|
Neurosci Biobehav Rev
|
2004
|
0.79
|
|
18
|
The GABA-A beta3 subunit mediates anaesthesia induced by etomidate.
|
Neuroreport
|
2004
|
0.78
|
|
19
|
Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
|
Bioorg Med Chem Lett
|
2006
|
0.77
|
|
20
|
Assessment of 'active investigation' as a potential measure of female sexual incentive motivation in a preclinical non-contact rodent model: observations with apomorphine.
|
Pharmacol Biochem Behav
|
2010
|
0.77
|
|
21
|
Potentiation of reflex erectile responses in the anaesthetized rat by the selective melanocortin receptor 4 agonist MB243.
|
BJU Int
|
2008
|
0.75
|
|
22
|
Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
|
Bioorg Med Chem Lett
|
2005
|
0.75
|
|
23
|
Guest editor's note.
|
Pharmacol Biochem Behav
|
2008
|
0.75
|